160 results on '"Pluchart, Claire"'
Search Results
2. Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?
- Author
-
Bougas, Nicolas, Allodji, Rodrigue S., Fayech, Chiraz, Haddy, Nadia, Mansouri, Imene, Journy, Neige, Demoor, Charlotte, Allard, Julie, Thebault, Eric, Surun, Aurore, Pacquement, Hélène, Pluchart, Claire, Bondiau, Pierre-Yves, Berchery, Delphine, Laprie, Anne, Boussac, Marjorie, Jackson, Angela, Souchard, Vincent, Vu-Bezin, Giao, Dufour, Christelle, Valteau-Couanet, Dominique, de Vathaire, Florent, Fresneau, Brice, and Dumas, Agnès
- Published
- 2023
- Full Text
- View/download PDF
3. Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
- Author
-
Raiser, Patricia, Schleiermacher, Gudrun, Gambart, Marion, Dumont, Benoit, Defachelles, Anne-Sophie, Thebaud, Estelle, Tandonnet, Julie, Pasqualini, Claudia, Proust, Stéphanie, Entz-Werle, Natacha, Aerts, Isabelle, Ndounga-Diakou, Lee A., Petit, Arnaud, Puiseux, Chloe, Khanfar, Camille, Rouger, Jeremie, Mansuy, Ludovic, Benadiba, Joy, Millot, Frédéric, Pluchart, Claire, Laghouati, Salim, Geoerger, Birgit, Vassal, Gilles, Valteau-Couanet, Dominique, and Berlanga, Pablo
- Published
- 2024
- Full Text
- View/download PDF
4. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus
- Author
-
Granel, Jérôme, Fernandes, Helder, Bader-Meunier, Brigitte, Guth, Amandine, Richer, Olivier, Pillet, Pascal, Leverger, Guy, Ducassou, Stéphane, Fahd, Mony, Pasquet, Marlène, Garnier, Nathalie, Barlogis, Vincent, Guitton, Corinne, Jeziorski, Eric, Thomas, Caroline, Bayart, Sophie, Cheikh, Nathalie, Paillard, Catherine, Abou Chahla, Wadih, Chastagner, Pascal, Neven, Bénédicte, Millot, Frédéric, Lejeune, Julien, Li-Thiao Te, Valérie, Armari-Alla, Corinne, Briandet, Claire, Carausu, Liana, Deparis, Marianna, Piguet, Christophe, Benadiba, Joy, Marie-Cardine, Aude, Stephan, Jean-Louis, Pellier, Isabelle, Pluchart, Claire, Doré, Eric, Michaux, Katell, Héritier, Sébastien, Leblanc, Thierry, and Aladjidi, Nathalie
- Published
- 2024
- Full Text
- View/download PDF
5. Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol
- Author
-
Merlin, Marie-Sophie, Schmitt, Emmanuelle, Mezloy-Destracque, Malika, Dufour, Christelle, Riffaud, Laurent, Puiseux, Chloé, De Carli, Emilie, Bodet, Damien, Icher, Céline, Doz, François, Faure-Conter, Cécile, Pagnier, Anne, Pluchart, Claire, Thouvenin-Doulet, Sandrine, Lejeune, Julien, Nguyen Thi, Phi-Linh, and Chastagner, Pascal
- Published
- 2023
- Full Text
- View/download PDF
6. Infections fongiques invasives chez l’enfant immunodéprimé en hématologie pédiatrique : recommandations de prise en charge au sein des centres de la SFCE
- Author
-
Alby-Laurent, Fanny, Chahla, Wadi Abou, Brethon, Benoît, Dupont, Damien, Gandemer, Virginie, Gueguen, Gwenaelle, Lanternier, Fanny, Pasquet, Marlène, Philippe, Michael, Pluchart, Claire, and Domenech, Carine
- Published
- 2022
- Full Text
- View/download PDF
7. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias
- Author
-
Pincez, Thomas, Aladjidi, Nathalie, Héritier, Sébastien, Garnier, Nathalie, Fahd, Mony, Abou Chahla, Wadih, Fernandes, Helder, Dichamp, Claire, Ducassou, Stéphane, Pasquet, Marlène, Bayart, Sophie, Moshous, Despina, Cheikh, Nathalie, Paillard, Catherine, Plantaz, Dominique, Jeziorski, Eric, Thomas, Caroline, Guitton, Corinne, Deparis, Marianna, Marie Cardine, Aude, Stephan, Jean-Louis, Pellier, Isabelle, Doré, Eric, Benadiba, Joy, Pluchart, Claire, Briandet, Claire, Barlogis, Vincent, Leverger, Guy, and Leblanc, Thierry
- Published
- 2022
- Full Text
- View/download PDF
8. Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.
- Author
-
Musoro, Jammbe, Sleurs, Charlotte, Rowsell, Ali, Suciu, Stefan, Kicinski, Michal, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie‐Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Van Der Werff ten Bosch, Jutte, Rohrlich, Pierre, Benoit, Yves, Piette, Caroline, and Darlington, Anne‐Sophie
- Published
- 2025
- Full Text
- View/download PDF
9. Long-term hospitalisations in survivors of paediatric solid tumours in France
- Author
-
Bejarano-Quisoboni, Daniel, Pelletier-Fleury, Nathalie, Allodji, Rodrigue S., Fresneau, Brice, Boussac, Majorie, Pacquement, Hélène, Doz, François, Berchery, Delphine, Pluchart, Claire, Bondiau, Piere-Yves, Nys, Julie, Jackson, Angela, Demoor-Goldschmidt, Charlotte, Dumas, Agnes, Thomas-Teinturier, Cécile, Schwartz, Boris, Journy, Neige, Rubino, Carole, Vu-Bezin, Giao, Valteau-Couanet, Dominique, El-Fayech, Chiraz, Dufour, Christelle, Haddy, Nadia, and de Vathaire, Florent
- Published
- 2022
- Full Text
- View/download PDF
10. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study
- Author
-
Olivier-Gougenheim, Laura, Rama, Nicolas, Dupont, Damien, Saultier, Paul, Leverger, Guy, AbouChahla, Wadih, Paillard, Catherine, Gandemer, Virginie, Theron, Alexandre, Freycon, Claire, Pluchart, Claire, Blouin, Pascale, Pellier, Isabelle, Thouvenin-Doulet, Sandrine, Desplantes, Claire, Ducassou, Stephane, Oudot, Caroline, Rouger-Gaudichon, Jeremie, Cheikh, Nathalie, Poiree, Maryline, Schneider, Pascale, Plat, Genevieve, Contet, Audrey, Rialland, Fanny, Gouache, Elodie, Brethon, Benoit, Bertrand, Yves, and Domenech, Carine
- Published
- 2021
- Full Text
- View/download PDF
11. Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia.
- Author
-
Domenech, Carine, Kicinski, Michal, De Moerloose, Barbara, Piette, Caroline, Chahla, Wadih A., Kornreich, Laure, Pasquet, Marlène, Uyttebroeck, Anne, Theron, Alexandre, Poirée, Marilyne, Arfeuille, Chloé, Bakkus, Marleen, Grardel, Nathalie, Paillard, Catherine, Freycon, Claire, Millot, Frédéric, Simon, Pauline, Philippet, Pierre, Pluchart, Claire, and Suciu, Stefan
- Published
- 2024
- Full Text
- View/download PDF
12. Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020
- Author
-
Magnier, Orlane, primary, Schiff, Isabelle, additional, Cristante, Justine, additional, Chabre, Olivier, additional, Veloso, Melanie, additional, Bosson, Jean‐Luc, additional, Defachelles, Anne‐Sophie, additional, Cordero, Camille, additional, Cao, Christine Do, additional, Thebaud, Estelle, additional, Drui, Delphine, additional, Berlanga, Pablo, additional, Dumont, Benoit, additional, Chastagner, Philippe, additional, Tandonnet, Julie, additional, Gambart, Marion, additional, Jannier, Sarah, additional, Pluchart, Claire, additional, Andry, Leslie, additional, Laithier, Véronique, additional, Klein, Sébastien, additional, Carausu, Liana, additional, Akbaraly, Tasmine, additional, Probert, Jamie, additional, Habert‐Dantigny, Raphaelle, additional, and Plantaz, Dominique, additional
- Published
- 2024
- Full Text
- View/download PDF
13. Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome
- Author
-
Pincez, Thomas, primary, Fernandes, Helder, additional, Fahd, Mony, additional, Pasquet, Marlène, additional, Chahla, Wadih Abou, additional, Granel, Jérome, additional, Ducassou, Stéphane, additional, Thomas, Caroline, additional, Garnier, Nathalie, additional, Jeziorski, Eric, additional, Bayart, Sophie, additional, Chastagner, Pascal, additional, Cheikh, Nathalie, additional, Guitton, Corinne, additional, Paillard, Catherine, additional, Lejeune, Julien, additional, Millot, Frédéric, additional, Li‐Thiao Te, Valérie, additional, Mallebranche, Coralie, additional, Pellier, Isabelle, additional, Castelle, Martin, additional, Armari‐Alla, Corinne, additional, Carausu, Liana, additional, Piguet, Christophe, additional, Benadiba, Joy, additional, Pluchart, Claire, additional, Stephan, Jean‐Louis, additional, Deparis, Marianna, additional, Briandet, Claire, additional, Doré, Eric, additional, Marie‐Cardine, Aude, additional, Barlogis, Vincent, additional, Leverger, Guy, additional, Héritier, Sébastien, additional, Aladjidi, Nathalie, additional, and Leblanc, Thierry, additional
- Published
- 2024
- Full Text
- View/download PDF
14. A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?
- Author
-
Pluchart, Claire, Barbe, Coralie, Poitevin, Gael, Audonnet, Sandra, and Nguyen, Philippe
- Published
- 2021
- Full Text
- View/download PDF
15. Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studies
- Author
-
de Ville de Goyet, Maëlle, Kicinski, Michal, Suciu, Stefan, Vandecruys, Els, Uyttebroeck, Anne, Ferster, Alina, Freycon, Claire, Plat, Geneviève, Thomas, Caroline, Barbati, Mélissa, Dresse, Marie-Françoise, Paillard, Catherine, Pluchart, Claire, Simon, Pauline, Chantrain, Christophe, Minckes, Odile, van der Werff Ten Bosch, Jutte, Bertrand, Yves, Rohrlich, Pierre, Millot, Frédéric, Paulus, Robert, Benoît, Yves, Piette, Caroline, de Ville de Goyet, Maëlle, Kicinski, Michal, Suciu, Stefan, Vandecruys, Els, Uyttebroeck, Anne, Ferster, Alina, Freycon, Claire, Plat, Geneviève, Thomas, Caroline, Barbati, Mélissa, Dresse, Marie-Françoise, Paillard, Catherine, Pluchart, Claire, Simon, Pauline, Chantrain, Christophe, Minckes, Odile, van der Werff Ten Bosch, Jutte, Bertrand, Yves, Rohrlich, Pierre, Millot, Frédéric, Paulus, Robert, Benoît, Yves, and Piette, Caroline
- Abstract
Survival after childhood acute lymphoblastic leukemia (ALL) has increased over the last 40 years with an overall survival above 90%. Survivors may experience neurological late effects secondary to chemotherapy and radiotherapy. This observational retrospective study evaluated the cumulative incidence of neurological late effects among 890 childhood ALL survivors treated in EORTC CLG trials (58741, 58831/2 and 58881) between 1971 and 1998. Median follow-up was 19 years and interquartile range of the follow-up was 15–22 years. At 20 years from the end of treatment, approximately 66% of patients from the 58741 trial (accrual time: 1971–1978) and approximately 15% from the more recent trials had cognitive disturbance grade 1 or higher. Cumulative incidences at 20 years from treatment end of seizures, stroke and leukoencephalopathy were respectively 45%, 16% and 62% in study 58741, 13%, 2% and 5% in study 58831/2, and 8%, 2% and 3% in study 58881. Patients who were 10–17 years of age at diagnosis had a higher incidence of stroke and leukoencephalopathy as compared to those less than 6 years of age. Noteworthy, all neurological late effects continued to occur beyond 5 years after end of treatment. This retrospective study highlights the frequency of neurological late effects in survivors of childhood ALL. With the increase of the overall survival of ALL patients, the role and potential benefit of longitudinal neurological screening should be evaluated in further studies as these neurological late effects become an important public health challenge. This study is part of the larger EORTC CLG 58 Late Adverse Effects (LAE) study (ClinicalTrials.gov Identifier NCT01298388, date of registration February 16, 2011)., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2024
16. Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus
- Author
-
Granel, Jérome, primary, Fernandes, Helder, additional, Bader-Meunier, Brigitte, additional, Guth, Amandine, additional, Richer, Olivier, additional, Pillet, Pascal, additional, Leverger, Guy, additional, Ducassou, Stéphane, additional, Fahd, Mony, additional, Pasquet, Marlène, additional, Garnier, Nathalie, additional, Barlogis, Vincent, additional, Guitton, Corinne, additional, Jeziorski, Eric, additional, Thomas, Caroline, additional, Bayart, Sophie, additional, Cheikh, Nathalie, additional, Paillard, Catherine, additional, Abou Chahla, Wadih, additional, Chastagner, Pascal, additional, Neven, Bénédicte, additional, Millot, Frédéric, additional, Lejeune, Julien, additional, Li Thiao Te, Valérie, additional, Armari-Alla, Corinne, additional, Briandet, Claire, additional, Carausu, Liana, additional, Deparis, Marianna, additional, Piguet, Christophe, additional, Benadiba, Joy, additional, Marie-Cardine, Aude, additional, Stephan, Jean-Louis Louis, additional, Pellier, Isabelle, additional, Pluchart, Claire, additional, Doré, Eric, additional, Michaux, Katell, additional, Heritier, Sebastien, additional, Leblanc, Thierry M, additional, and Aladjidi, Nathalie, additional
- Published
- 2024
- Full Text
- View/download PDF
17. Chemo-Immunotherapy with Dinutuximab Beta in Patients with Progressive High-Risk Neuroblastoma: Does Chemotherapy Backbone Matter?
- Author
-
Raiser, Patricia, primary, Schleiermacher, Gudrun, additional, Gambart, Marion, additional, Dumont, Benoit, additional, Desfachelles, Anne-Sophie, additional, Thebaud, Estelle, additional, Tandonnet, Julie, additional, Pasqualini, C., additional, Proust, Stéphanie, additional, Entz-Werle, Natacha, additional, Aerts, Isabelle, additional, Ndounga-Diakou, Lee Aymar, additional, Petit, Arnaud, additional, Puiseux, Chloe, additional, Andry, Leslie, additional, Rouger, Jeremie, additional, Mansuy, Ludovic, additional, Benadiba, Joy, additional, Millot, Frédéric, additional, Pluchart, Claire, additional, Laghouati, Salim, additional, Geoerger, Birgit, additional, Vassal, Gilles, additional, Valteau-Couannet, Dominique, additional, and Berlanga, Pablo, additional
- Published
- 2024
- Full Text
- View/download PDF
18. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles
- Author
-
Pluchart, Claire, Poitevin, Gael, Colinart-Thomas, Maud, Guimard, Gregory, Audonnet, Sandra, Terryn, Christine, and Nguyen, Philippe
- Published
- 2019
- Full Text
- View/download PDF
19. A 16-year bicentric retrospective analysis of ovarian tissue cryopreservation in pediatric units: indications, results, and outcome
- Author
-
Grellet-Grün, Marine, primary, Delepine, Béatrice, additional, Le Van Quyen, Pauline, additional, Avérous, Gerlinde, additional, Durlach, Anne, additional, Greze, Cécile, additional, Ladureau-Fritsch, Laetitia, additional, Lichtblau, Isabelle, additional, Canepa, Anne-Sophie, additional, Liné, Antoine, additional, Paillard, Catherine, additional, Pluchart, Claire, additional, Pirrello, Olivier, additional, Rongieres, Catherine, additional, Harika, Ghassan, additional, Becmeur, François, additional, and Teletin, Marius, additional
- Published
- 2023
- Full Text
- View/download PDF
20. Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
- Author
-
Berlanga, Pablo, primary, Ndounga-Diakou, Lee Aymar, additional, Aerts, Isabelle, additional, Corradini, Nadège, additional, Ducassou, Stéphane, additional, Strullu, Marion, additional, de Carli, Emilie, additional, André, Nicolas, additional, Entz-Werle, Natacha, additional, Raimbault, Sandra, additional, Roumy, Marianne, additional, Renouard, Marjolaine, additional, Gueguen, Gwenaelle, additional, Plantaz, Dominique, additional, Reguerre, Yves, additional, Cleirec, Morgane, additional, Petit, Arnaud, additional, Puiseux, Chloe, additional, Andry, Leslie, additional, Klein, Sébastien, additional, Bodet, Damien, additional, Kanold, Justyna, additional, Briandet, Claire, additional, Halfon-Domenech, Carine, additional, Nelken, Brigitte, additional, Piguet, Christophe, additional, Saumet, Laure, additional, Chastagner, Pascal, additional, Benadiba, Joy, additional, Millot, Frédéric, additional, Pluchart, Claire, additional, Schneider, Pascale, additional, Thouvenin, Sandrine, additional, Gambart, Marion, additional, Serre, Jill, additional, Abbou, Samuel, additional, Leruste, Amaury, additional, Cayzac, Hélena, additional, Gandemer, Virginie, additional, Laghouati, Salim, additional, and Vassal, Gilles, additional
- Published
- 2023
- Full Text
- View/download PDF
21. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia
- Author
-
Pincez, Thomas, primary, Fernandes, Helder, additional, Pasquet, Marlène, additional, Abou Chahla, Wadih, additional, Granel, Jérome, additional, Héritier, Sébastien, additional, Fahd, Mony, additional, Ducassou, Stéphane, additional, Thomas, Caroline, additional, Garnier, Nathalie, additional, Barlogis, Vincent, additional, Jeziorski, Eric, additional, Bayart, Sophie, additional, Chastagner, Pascal, additional, Cheikh, Nathalie, additional, Guitton, Corinne, additional, Paillard, Catherine, additional, Lejeune, Julien, additional, Millot, Frédéric, additional, Li‐Thiao Te, Valérie, additional, Mallebranche, Coralie, additional, Pellier, Isabelle, additional, Neven, Bénédicte, additional, Armari‐Alla, Corinne, additional, Carausu, Liana, additional, Piguet, Christophe, additional, Benadiba, Joy, additional, Pluchart, Claire, additional, Stephan, Jean‐Louis, additional, Deparis, Marianna, additional, Briandet, Claire, additional, Doré, Eric, additional, Marie‐Cardine, Aude, additional, Leblanc, Thierry, additional, Leverger, Guy, additional, and Aladjidi, Nathalie, additional
- Published
- 2023
- Full Text
- View/download PDF
22. Quality of Life of Long‐term childhood Acute Lymphoblastic Leukemia survivors: Comparison with healthy controls
- Author
-
Chantziara, Sofia, Musoro, Jammbe, Rowsell, Alison C., Sleurs, Charlotte, Coens, Corneel, Pe, Madeline, Suciu, Stefan, Kicinski, Michal, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie‐françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Van Der Werff Ten Bosch, Jutte, Rohrlich, Pierre, Benoit, Yves, Darlington, Anne‐sophie, Piette, Caroline, And On Behalf Of The European Organisation For Research, and Group (clg, Treatment Of Cancer (eortc) Quality Of Life (qlg) And Childr
- Abstract
Objective: Improved treatment landscape has led to better outcomes for paediatric acute lymphoblastic leukemia (ALL) survivors. As the number of survivors increase, we need to elucidate the long-term quality of life (QoL) and domains of complaints in these patients. Furthermore, the main priorities of these patients need to be clarified. We assessed long-term QoL outcomes of survivors of childhood ALL compared to matched population controls.Methods: QoL data were collected from survivors recruited in France and Belgium between 2012 and 2017, including the Short Form Health Survey (SF-12) and the Quality of Life Systemic Inventory (QLSI). The Wilcoxon test was used to compare SF-12 scale scores between survivors and matched population controls. For the QLSI, comparisons were mainly descriptive.Results: one hundred and eighty-six survivors (mean age: 27.6 years; range: 18.1–52.8) at follow-up completed QoL measures, amongst whom 180 were matched to controls. Overall, survivors had higher QoL on all SF12 scale scores, indicating that they had better functioning compared to controls. Statistically significant differences on the SF12 were observed for Vitality, Social Functioning, Role Limitations due to Emotional Problems and Mental Health scales. QLSI outcomes suggested that survivors were happier than controls with Couple and Social Relations. Controls were unhappiest compared to survivors with Money, Love life, Self-esteem, Nutrition and Paid Work.Conclusions: our findings suggest that survivors of childhood ALL have better QoL outcomes on some domains compared to the general population, specifically around social and emotional functioning, and that they tend to prioritize their relationships more. Interventions for improving QoL outcomes, might build on existing positive experiences with family, friends and partners.
- Published
- 2022
23. Recommandations: Infections fongiques invasives chez l’enfant immunodéprimé en hématologie pédiatrique : recommandations de prise en charge au sein des centres de la SFCE
- Author
-
Alby-Laurent, Fanny, Chahla, Wadi Abou, Brethon, Benoit, Dupont, Damien, Gandemer, Virginie, Gueguen, Gwénaelle, Lanternier, Fanny, Pasquet, Marlène, Philippe, Michaël, Pluchart, Claire, Domenech, Carine, CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Lille, Hôpital Robert Debré, Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), CHU Pontchaillou [Rennes], Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Institut Gustave Roussy (IGR), Département de cancérologie de l'enfant et de l'adolescent [Gustave Roussy], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Léon Bérard [Lyon], Centre Hospitalier Universitaire de Reims (CHU Reims), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, and Institut d'hématologie et d'oncologie pédiatrique [CHU - HCL] (IHOPe)
- Subjects
[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics ,Prophylaxis ,Leucémie de l’enfant ,[SDV]Life Sciences [q-bio] ,Childhood leukaemia ,Treatment ,Infection fongique invasive ,Invasive fungal infection ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Diagnosis ,Prophylaxie ,Diagnostic ,Traitement ,[SDV.MP.MYC]Life Sciences [q-bio]/Microbiology and Parasitology/Mycology - Abstract
National audience; INTRODUCTION: To date, invasive fungal infections (IFIs) are still responsible for a high mortality rate in children managed for haematological malignancy. Although Candida and Aspergillus infections remain in the majority, emerging fungal infections are increasingly common. Children differ from adults in their pathology and treatment, as well as in their prior fungal colonisation and unique pharmacokinetics. Therefore, we propose here specific paediatric management recommendations for IFIs in haematology. METHODS: We based our recommendations on a review of the literature, including the latest ECIL recommendations, an analysis of practices and a collection of expert opinions. RESULTS AND DISCUSSION: In France, approximately 5% of children treated for haematological malignancy or who have received a bone marrow allograft present an IFI. These IFIs are equally divided between yeast infections (mainly due to Candida albicans) and filamentous infections (mainly aspergillosis) and 16% are IFIs due to emerging fungi, half of which are due to Mucorales. In these recommendations, we recall the diagnostic criteria for proven or probable IFI according to the Donnelly classification, then we propose strategies for screening, diagnosing, evaluating the extension and treating these three types of IFI. We also detail the diagnostic and therapeutic management of chronic disseminated candidiasis. We also discuss prophylactic measures, including environmental measures which are of primary importance in children.; IntroductionLes infections fongiques invasives (IFI) sont encore responsables d’un taux élevé de mortalité chez les enfants pris en charge pour une hémopathie maligne. Bien que les infections à Candida et Aspergillus demeurent majoritaires, des infections à champignons émergents sont de plus en plus fréquentes. Les enfants diffèrent des adultes, tant par leur pathologie et leur traitement, que par leur colonisation fongique préalable et une pharmacocinétique qui leur est propre. Aussi, nous proposons ici des recommandations de prise en charge pédiatriques spécifiques des IFI en hématologie.MéthodesNous nous sommes appuyés sur une analyse de la littérature incluant les dernières recommandations de l’ECIL (European Conference on Infections in Leukaemia), sur une analyse des pratiques et un recueil d’avis d’experts.Résultats et discussionEn France, environ 5 % des enfants traités pour une hémopathie maligne ou ayant bénéficié d’une allogreffe de cellules souches hématopoïétiques présentent une IFI. Ces IFI sont réparties, de façon égale, entre infections à levures (majoritairement dues à Candida albicans) et filamenteux (aspergilloses principalement) et 16 % sont des IFI à champignons émergents, dont la moitié à Mucorales. Dans ces recommandations, nous rappelons les critères diagnostiques d’IFI prouvée ou probable selon la classification de Donnelly ; puis, nous proposons des stratégies pour dépister, diagnostiquer, évaluer l’extension et traiter ces trois types d’IFI. Nous détaillons aussi la prise en charge diagnostique et thérapeutique des candidoses disséminées chroniques. Nous évoquons également les mesures prophylactiques, incluant les mesures environnementales qui sont au premier plan chez l’enfant.
- Published
- 2022
- Full Text
- View/download PDF
24. Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study
- Author
-
European Organisation for Research and Treatment of Cancer (EORTC) Children's Leukemia Group (CLG), Barbati, Melissa, Kicinski, Michal, Suciu, Stefan, Mazingue, Françoise, Vandecruys, Els, Plat, Geneviève, Uyttebroeck, Anne, Paillard, Catherine, Dresse, Marie-Françoise, Simon, Pauline, Pluchart, Claire, Minckes, Odile, Ferster, Alina, Freycon, Claire, Millot, Frederic, Van Der Werff Ten Bosch, Jutte, Chantrain, Christophe, Paulus, Robert, de Schaetzen, Gaetan, Rossi, Giovanna, Rohrlich, Pierre, Benoit, Yves, Piette, Caroline, Brussels Heritage Lab, and Growth and Development
- Subjects
Adult ,Employment ,Marital Status ,hematology ,oncology ,Humans ,Pediatrics, Perinatology, and Child Health ,Survivors ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,Cranial Irradiation ,Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy - Abstract
OBJECTIVE: The objective of this study is to evaluate the socio-economic outcomes of survivors of childhood acute lymphoblastic leukaemia (ALL). METHODS: Childhood ALL adult survivors, enrolled in EORTC trials between 1971 and 1998 in France and Belgium, were invited to fill out a questionnaire with information about their socio-economic situation (living with a partner, having a university degree, having a job, working part time and history of having a paid job). The outcomes were compared with two matched control populations. RESULTS: Among 1418 eligible patients, 507 (35.8%) participated, including 39 (8%) and 61 (12%) patients who received a haematopoietic stem cell transplantation (HSCT) and a cranial radiotherapy (CRT), respectively. The median time to follow-up was 20 years, and median age was 25 years. Survivors showed a socio-economic level at least as good as controls. HCST and CRT were associated with a higher probability of not obtaining a bachelor degree (respectively OR = 3.49, 95% CI: 1.46-8.35 and OR = 2.31, 95% CI: 1.04-5.15), HSCT was associated with unemployment (OR = 2.89, 95% CI: 1.09-7.65) and having a relapse was associated with a higher probability of not having a partner (OR = 1.88, 95% CI: 1.01-3.51) adjusting for confounders. CONCLUSION: Childhood ALL survivors showed a high level of socio-economic participation. HCST and CRT were associated with poorer functioning.
- Published
- 2022
25. Risk factors for obesity in adulthood among survivors of childhood cancer.
- Author
-
Delacourt, Laurène, Allodji, Rodrigue, Chappat, Juliette, Haddy, Nadia, El‐Fayech, Chiraz, Demoor‐Goldschmidt, Charlotte, Journy, Neige, Bolle, Stéphanie, Thomas‐Teinturier, Cécile, Zidane, Monia, Rubino, Carole, Veres, Cristina, Vu‐Bezin, Giao, Berchery, Delphine, Pluchart, Claire, Bondiau, Pierre‐Yves, Dumas, Agnès, Bougas, Nicolas, Grill, Jacques, and Dufour, Christelle
- Subjects
CHILDHOOD cancer ,ADULTS ,CANCER survivors ,FRENCH people ,OBESITY ,BRAIN tumors ,RADIATION carcinogenesis - Abstract
Objective: The aim of this study was to identify risk factors for obesity in childhood cancer survivors (CCSs). Methods: The study included 3199 patients of the French Childhood Cancer Survivor Study cohort, with 303 patients with obesity who had returned the self‐questionnaire. Analyses were adjusted for social deprivation index and sex. Results: CCSs were less likely to have obesity (9.5%; 95% CI: 8.5%–10.5%) than expected from the general French population rates (12.5%; p = 0.0001). Nevertheless, brain tumor survivors were significantly more likely to develop obesity than the general French population (p = 0.0001). Compared with patients who did not receive radiotherapy to the pituitary gland, those who received a dose >5 Gy had an increased risk of obesity: relative risk 1.9 (95% CI: 1.2–3.1), 2.5 (95% CI: 1.7–3.7), and 2.6 (95% CI: 1.6–4.3), respectively, for participants with 6 to 20 Gy, 20 to 40 Gy, and ≥40 Gy of radiation. Etoposide administration significantly increased the risk of obesity (relative risk 1.7; 95% CI: 1.1–2.6). High social deprivation index was also a risk factor, just like BMI at diagnosis. Conclusions: Long‐term follow‐up of CCSs should include weight follow‐up during adulthood. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments
- Author
-
Chargari, Cyrus, primary, Haie-Meder, Christine, additional, Espenel, Sophie, additional, Garcia, Max-Adrien, additional, Ben-Arush, Myriam, additional, Bolle, Stéphanie, additional, Borjesson, Anna, additional, Cesen, Maja, additional, Lago, Rita Costa, additional, Defachelles, Anne-Sophie, additional, De Moerloose, Barbara, additional, Devalck, Christine, additional, Edslev, Pernille, additional, Farinha, Nuno Jorge, additional, Francotte, Nadine, additional, Glosli, Heidi, additional, Gouy, Sebastien, additional, Burrieza, Gabriela Guillen, additional, Helfre, Sylvie, additional, Irtan, Sabine, additional, Kattamis, Antonis, additional, Lacerda, Ana, additional, Levy, Antonin, additional, Hjalgrim, Lisa Lyngsie, additional, Mansuy, Ludovic, additional, Mascard, Eric, additional, Moalla, Salma, additional, Orbach, Daniel, additional, Owens, Cormac, additional, Philippe-Chomette, Pascale, additional, Pizer, Barry, additional, Pluchart, Claire, additional, Renard, Marleen, additional, Rognlien, Anne Gro Wesenberg, additional, Rome, Angélique, additional, Sarnacki, Sabine, additional, Safwat, Akmal, additional, Schiavetti, Amalia, additional, Serre, Jill, additional, Verite, Cécile, additional, Weid, Nicolas Von Der, additional, Wysocki, Mariusz, additional, Valteay-Couanet, Dominique, additional, Deutsch, Eric, additional, Minard-Colin, Véronique, additional, Martelli, Hélène, additional, and Guérin, Florent, additional
- Published
- 2022
- Full Text
- View/download PDF
27. MEDB-13. Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol
- Author
-
Merlin, Marie-Sophie, primary, Schmitt, Emmanuelle, additional, Mezloy-Destracque, Malika, additional, Dufour, Christelle, additional, Riffaud, Laurent, additional, Puiseux, Chloé, additional, De Carli, Emilie, additional, Bodet, Damien, additional, Icher, Céline, additional, Doz, François, additional, Faure-Conter, Cécile, additional, Pagnier, Anne, additional, Pluchart, Claire, additional, Thouvenin-Doulet, Sandrine, additional, Lejeune, Julien, additional, Thi-Lambert, Phi-Linh Nguyen, additional, and Chastagner, Pascal, additional
- Published
- 2022
- Full Text
- View/download PDF
28. Brachytherapy for pediatric patients at Gustave Roussy Cancer Campus: A model of international cooperation for highly specialized treatments.
- Author
-
Chargari, Cyrus Haie-Meder, Christine Espenel, Sophie Garcia, Max-Adrien Ben-Arush, Myriam Bolle, Stéphanie Borjesson, Anna Cesen, Maja Lago, Rita Costa Defachelles, Anne-Sophie De Moerloose, Barbara Devalck, Christine Edslev, Pernille Farinha, Nuno Jorge Francotte, Nadine Glosli, Heidi Gouy, Sebastien Burrieza, Gabriela Guillen Helfre, Sylvie Irtan, Sabine Kattamis, Antonis Lacerda, Ana Levy, Antonin Hjalgrim, Lisa Lyngsie Mansuy, Ludovic Mascard, Eric Moalla, Salma Orbach, Daniel Owens, Cormac Philippe-Chomette, Pascale Pizer, Barry Pluchart, Claire Renard, Marleen Rognlien, Anne Gro Wesenberg Rome, Angélique Sarnacki, Sabine Safwat, Akmal Schiavetti, Amalia Serre, Jill Verite, Cécile Weid, Nicolas Von Der Wysocki, Mariusz Valteay-Couanet, Dominique Deutsch, Eric Minard-Colin, Véronique Martelli, Hélène Guérin, Florent and Chargari, Cyrus Haie-Meder, Christine Espenel, Sophie Garcia, Max-Adrien Ben-Arush, Myriam Bolle, Stéphanie Borjesson, Anna Cesen, Maja Lago, Rita Costa Defachelles, Anne-Sophie De Moerloose, Barbara Devalck, Christine Edslev, Pernille Farinha, Nuno Jorge Francotte, Nadine Glosli, Heidi Gouy, Sebastien Burrieza, Gabriela Guillen Helfre, Sylvie Irtan, Sabine Kattamis, Antonis Lacerda, Ana Levy, Antonin Hjalgrim, Lisa Lyngsie Mansuy, Ludovic Mascard, Eric Moalla, Salma Orbach, Daniel Owens, Cormac Philippe-Chomette, Pascale Pizer, Barry Pluchart, Claire Renard, Marleen Rognlien, Anne Gro Wesenberg Rome, Angélique Sarnacki, Sabine Safwat, Akmal Schiavetti, Amalia Serre, Jill Verite, Cécile Weid, Nicolas Von Der Wysocki, Mariusz Valteay-Couanet, Dominique Deutsch, Eric Minard-Colin, Véronique Martelli, Hélène Guérin, Florent
- Abstract
PURPOSE: Childhood cancer is rare, and treatment is frequently associated with long-term morbidity. Disparities in survival and long-term side-effects encourage the establishment of networks to increase access to complex organ conservative strategies, such as brachytherapy (BT). We report our experience of an international cooperation model in childhood cancers. METHODS AND MATERIALS: We examined the outcome of all children referred to our center from national or international networks to be treated according to a multimodal organ-conservative approach including BT. RESULTS: 305 patients were identified; median age at diagnosis was 2.2 years (1.4 months-17.2 years). Ninety-nine (32.4%) were treated within 2015-2020. One hundred seventy-two (56.4%) were referred from national centers and 133 (43.6%) were international patients, from 31 countries (mainly Europe). Two hundred sixty three patients were referred for primary treatment and 42 for salvage treatment. Genito-urinary tumors were the most frequent sites, with 56.4% bladder/prostate rhabdomyosarcoma (RMS) and 28.5% gynecological tumors. In addition to BT, local treatment comprised partial tumor resection in 207 (67.9%) and 39 (13%) had additional external radiotherapy. Median follow-up was 58 months (range: 1 month-48 years), 93 months for national patients and 37 months for international patients (p<.0001). Five-year local control (LC), disease-free survival (DFS) and overall survival rates were 90.8% (CI95%: 87.3-94.4%), 84.4% (CI95%:80.1-89.0) and 93.3% (CI95%:90.1-96.5), respectively. Patients referred for salvage treatment had poorer DFS (p<0.01). Implementation of image-guided pulse-dose rate BT was associated with better LC among RMS patients referred for primary treatment (HR: 9.72; CI95%:1.24-71.0). At last follow-up, 16.7% patients had long-term severe treatment-related complications and two (0.7%) had developed second malignancy. CONCLUSION: This retrospective series shows the feasibility of a m
- Published
- 2022
29. Quality of life of long-term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controls
- Author
-
European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLG) and Children's Leukemia Group (CLG), Chantziara, Sofia, Musoro, Jammbe, Rowsell, Alison C, Sleurs, Charlotte, Coens, Corneel, Pe, Madeline, Suciu, Stefan, Kicinski, Michal, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Bosch, Jutte Van Der Werff Ten, Rohrlich, Pierre, Benoit, Yves, Darlington, Anne-Sophie, Piette, Caroline, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLG) and Children's Leukemia Group (CLG), Chantziara, Sofia, Musoro, Jammbe, Rowsell, Alison C, Sleurs, Charlotte, Coens, Corneel, Pe, Madeline, Suciu, Stefan, Kicinski, Michal, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Bosch, Jutte Van Der Werff Ten, Rohrlich, Pierre, Benoit, Yves, Darlington, Anne-Sophie, and Piette, Caroline
- Abstract
Objective: Improved treatment landscape has led to better outcomes for paediatric acute lymphoblastic leukemia (ALL) survivors. As the number of survivors increase, we need to elucidate the long-term quality of life (QoL) and domains of complaints in these patients. Furthermore, the main priorities of these patients need to be clarified. We assessed long-term QoL outcomes of survivors of childhood ALL compared to matched population controls.Methods: QoL data were collected from survivors recruited in France and Belgium between 2012 and 2017, including the Short Form Health Survey (SF-12) and the Quality of Life Systemic Inventory (QLSI). The Wilcoxon test was used to compare SF-12 scale scores between survivors and matched population controls. For the QLSI, comparisons were mainly descriptive.Results: One hundred and eighty-six survivors (mean age: 27.6 years; range: 18.1-52.8) at follow-up completed QoL measures, amongst whom 180 were matched to controls. Overall, survivors had higher QoL on all SF12 scale scores, indicating that they had better functioning compared to controls. Statistically significant differences on the SF12 were observed for Vitality, Social Functioning, Role Limitations due to Emotional Problems and Mental Health scales. QLSI outcomes suggested that survivors were happier than controls with Couple and Social Relations. Controls were unhappiest compared to survivors with Money, Love life, Self-esteem, Nutrition and Paid Work.Conclusions: Our findings suggest that survivors of childhood ALL have better QoL outcomes on some domains compared to the general population, specifically around social and emotional functioning, and that they tend to prioritize their relationships more. Interventions for improving QoL outcomes, might build on existing positive experiences with family, friends and partners.
- Published
- 2022
30. Sociodemographic and medical determinants of quality of life in long-term childhood acute lymphoblastic leukemia survivors enrolled in EORTC CLG studies
- Author
-
European Organisation Res Treatme, Childrens Leukemia Grp CLG, Sleurs, Charlotte, Musoro, Jammbe, Rowsell, Ali, Kicinski, Michal, Suciu, Stefan, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Francoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, ten Bosch, Jutte van der Werff, Rohrlich, Pierre-Simon, Benoit, Yves, Darlington, Anne-Sophie, Piette, Caroline, European Organisation Res Treatme, Childrens Leukemia Grp CLG, Sleurs, Charlotte, Musoro, Jammbe, Rowsell, Ali, Kicinski, Michal, Suciu, Stefan, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Francoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, ten Bosch, Jutte van der Werff, Rohrlich, Pierre-Simon, Benoit, Yves, Darlington, Anne-Sophie, and Piette, Caroline
- Abstract
Simple Summary Long-term quality of life and its potential risk factors in childhood acute lymphoblastic leukemia (ALL) patients remain uncertain. In this cross-sectional study, we investigated daily life quality and life challenges in adult survivors of ALL using multiple self-report questionnaires. Furthermore, risk factors, including gender, age at diagnosis, relapse/second neoplasm, risk group, and cranial radiotherapy, were explored in detail. Younger, female, and relapsed patients appeared to encounter more life challenges, while physical challenges occurred more often in relapsed and high-risk patients. More positive effects on socializing were found in the older patients compared to younger patients. This study provides important information for individual and specialized support. Background: due to increasing survival rates in childhood acute lymphoblastic leukemia (ALL), the number of survivors has been expanding. A significant proportion of these survivors can experience long-term emotional and psychosocial problems. However, the exact risk factors remain inconclusive. We investigated potential risk factors for decreased daily life quality and life challenges in long-term childhood ALL survivors enrolled between 1971 and 1998 in EORTC studies. Methods: self-report questionnaires were collected from 186 survivors (109 females; mean age at diagnosis 5.62 years, range 0.2-14.7; median time since diagnosis of 20.5 years (12.9-41.6)), including the Short-Form Health Survey (SF-12) and Impact of Cancer-Childhood Survivors (IOC-CS). Multivariable linear regression models were used to assess the impact of gender, age at diagnosis, relapse/second neoplasm, National Cancer Institute (NCI) risk group and cranial radiotherapy on 2 subscales of the SF-12 (physical and mental health) and five subscales of the IOC-CS (life challenges, body and health, personal growth, thinking and memory problems and socializing). Results: mental component scores of SF-12 were not si
- Published
- 2022
31. Sociodemographic and medical determinants of quality of life in long-term childhood acute lymphoblastic leukemia survivors enrolled in eortc clg studies
- Author
-
Sleurs, Charlotte, Musoro, Jammbe, Rowsell, Ali, Kicinski, Michal, Suciu, Stefan, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Ten Bosch, Jutte van der Werff J.v.d.W., Rohrlich, Pierre, Benoît, Yves, Darlington, Anne Sophie, Piette, Caroline, Sleurs, Charlotte, Musoro, Jammbe, Rowsell, Ali, Kicinski, Michal, Suciu, Stefan, Chantziara, Sofia, Coens, Corneel, Pe, Madeline, Missotten, Pierre, Vandecruys, Els, Uyttebroeck, Anne, Dresse, Marie-Françoise, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Ten Bosch, Jutte van der Werff J.v.d.W., Rohrlich, Pierre, Benoît, Yves, Darlington, Anne Sophie, and Piette, Caroline
- Abstract
Background: due to increasing survival rates in childhood acute lymphoblastic leukemia (ALL), the number of survivors has been expanding. A significant proportion of these survivors can experience long-term emotional and psychosocial problems. However, the exact risk factors remain inconclusive. We investigated potential risk factors for decreased daily life quality and life challenges in long-term childhood ALL survivors enrolled between 1971 and 1998 in EORTC studies. Methods: self-report questionnaires were collected from 186 survivors (109 females; mean age at diagnosis 5.62 years, range 0.2–14.7; median time since diagnosis of 20.5 years (12.9–41.6)), including the Short-Form Health Survey (SF-12) and Impact of Cancer-Childhood Survivors (IOC-CS). Multivariable linear regression models were used to assess the impact of gender, age at diagnosis, relapse/second neoplasm, National Cancer Institute (NCI) risk group and cranial radiotherapy on 2 subscales of the SF-12 (physical and mental health) and five subscales of the IOC-CS (life challenges, body and health, personal growth, thinking and memory problems and socializing). Results: mental component scores of SF-12 were not significantly associated with any risk factor. Physical component scores were lower in relapsed, irradiated and NCI high-risk patients. Regarding IOC-CS negative impact subscales, life challenges was more negatively impacted by cancer in female, younger (i.e. <6 years) and relapsed patients. Regarding the positive impact scales, personal growth was more positively impacted in relapsed patients, whereas body and health, and socializing, were less positively impacted in these patients, compared to non-relapsed patients. Socializing was more positively impacted in older patients (>6 years). Conclusions: this study demonstrates that long-term outcomes can be both adverse and positive, depending on the patient’s demographic and clinical characteristics. Younger, female, and relapsed patients might e, SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2022
32. Fertility Status Among Long-Term Childhood Acute Lymphoblastic Leukaemia Survivors Enrolled Between 1971 and 1998 in EORTC CLG Studies: Results of the 58 Late Adverse Effects Study
- Author
-
Rossi, Giovanna, primary, Kicinski, Michal, additional, Suciu, Stefan, additional, Vandecruys, Els, additional, Plat, Geneviève, additional, Uyttebroeck, Anne, additional, Paillard, Catherine, additional, Barbati, Mélissa, additional, Dresse, Marie-Françoise, additional, Simon, Pauline, additional, Minckes, Odile, additional, Pluchart, Claire, additional, Ferster, Alina, additional, Freycon, Claire, additional, Millot, Frederic, additional, van der Werff ten Bosch, Jutte, additional, Chantrain, Christophe, additional, Paulus, Robert, additional, de Rojas, Teresa, additional, de Schaetzen, Gaetan, additional, Rohrlich, Pierre, additional, Benoit, Yves, additional, and Piette, Caroline, additional
- Published
- 2022
- Full Text
- View/download PDF
33. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer
- Author
-
Delebarre, Mathilde, primary, Gonzales, Fanny, additional, Behal, Hélène, additional, Tiphaine, Aude, additional, Sudour-Bonnange, Hélène, additional, Lutun, Anne, additional, Abbou, Samuel, additional, Pertuisel, Sophie, additional, Thouvenin-Doulet, Sandrine, additional, Pellier, Isabelle, additional, Mansuy, Ludovic, additional, Piguet, Christophe, additional, Paillard, Catherine, additional, Blanc, Laurence, additional, Thebaud, Estelle, additional, Plantaz, Dominique, additional, Blouin, Pascale, additional, Schneider, Pascale, additional, Guillaumat, Cécile, additional, Simon, Pauline, additional, Domenech, Carine, additional, Pacquement, Hélène, additional, Le Meignen, Marion, additional, Pluchart, Claire, additional, Vérite, Cécile, additional, Plat, Geneviève, additional, Martinot, Alain, additional, Duhamel, Alain, additional, and Dubos, François, additional
- Published
- 2022
- Full Text
- View/download PDF
34. Les livres, les enfants et les parents : deux crèches témoignent
- Author
-
Boyer, Christine, primary, Tisserand, Mireille, additional, Pluchart, Claire, additional, Basinc, Michelle, additional, Pozzi, Claire, additional, and Driss, Rachida, additional
- Published
- 2016
- Full Text
- View/download PDF
35. Response to Induction Therapy in Pediatric Hodgkin’s Lymphoma: Performance of First-Order Texture Parameters of CT Images
- Author
-
Doillon, Margaux, primary, Durot, Carole, additional, Pluchart, Claire, additional, Marcus, Claude, additional, Djelouah, Manel, additional, and Carsin-Vu, Aline, additional
- Published
- 2022
- Full Text
- View/download PDF
36. Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies
- Author
-
Sleurs, Charlotte, primary, Musoro, Jammbe, additional, Rowsell, Ali, additional, Kicinski, Michal, additional, Suciu, Stefan, additional, Chantziara, Sofia, additional, Coens, Corneel, additional, Pe, Madeline, additional, Missotten, Pierre, additional, Vandecruys, Els, additional, Uyttebroeck, Anne, additional, Dresse, Marie-Françoise, additional, Pluchart, Claire, additional, Ferster, Alina, additional, Freycon, Claire, additional, van der Werff ten Bosch, Jutte, additional, Rohrlich, Pierre-Simon, additional, Benoit, Yves, additional, Darlington, Anne-Sophie, additional, and Piette, Caroline, additional
- Published
- 2021
- Full Text
- View/download PDF
37. Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study
- Author
-
Aubert, Lucie, primary, Petit, Arnaud, additional, Bertrand, Yves, additional, Ray‐Lunven, Anne‐France, additional, Angoso, Marie, additional, Pluchart, Claire, additional, Millot, Frédéric, additional, Saultier, Paul, additional, Cheikh, Nathalie, additional, Pellier, Isabelle, additional, Plantaz, Dominique, additional, Sirvent, Anne, additional, Thouvenin‐Doublet, Sandrine, additional, Valduga, Julie, additional, Plat, Geneviève, additional, Rialland, Fanny, additional, Henry, Catherine, additional, Esvan, Maxime, additional, and Gandemer, Virginie, additional
- Published
- 2021
- Full Text
- View/download PDF
38. Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study
- Author
-
Rossi, Giovanna, primary, Kicinski, Michal, additional, Suciu, Stefan, additional, Vandecruys, Els, additional, Plat, Geneviève, additional, Uyttebroeck, Anne, additional, Paillard, Catherine, additional, Barbati, Mélissa, additional, Dresse, Marie-Françoise, additional, Simon, Pauline, additional, Minckes, Odile, additional, Pluchart, Claire, additional, Ferster, Alina, additional, Freycon, Claire, additional, Millot, Frederic, additional, van der Werff ten Bosch, Jutte, additional, Chantrain, Christophe, additional, Paulus, Robert, additional, de Rojas, Teresa, additional, de Schaetzen, Gaetan, additional, Rohrlich, Pierre, additional, Benoit, Yves, additional, and Piette, Caroline, additional
- Published
- 2021
- Full Text
- View/download PDF
39. Socio‐economic outcomes among long‐term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.
- Author
-
Barbati, Melissa, Kicinski, Michal, Suciu, Stefan, Mazingue, Françoise, Vandecruys, Els, Plat, Geneviève, Uyttebroeck, Anne, Paillard, Catherine, Dresse, Marie‐Françoise, Simon, Pauline, Pluchart, Claire, Minckes, Odile, Ferster, Alina, Freycon, Claire, Millot, Frederic, Van Der Werff ten Bosch, Jutte, Chantrain, Christophe, Paulus, Robert, de Schaetzen, Gaetan, and Rossi, Giovanna
- Subjects
LYMPHOBLASTIC leukemia prognosis ,LYMPHOBLASTIC leukemia treatment ,CANCER patient psychology ,CONFIDENCE intervals ,UNEMPLOYMENT ,LYMPHOBLASTIC leukemia ,TUMORS in children ,PATIENTS' attitudes ,COMPARATIVE studies ,SOCIAL classes ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,EMPLOYMENT ,RESEARCH funding ,HEMATOPOIETIC stem cell transplantation ,ODDS ratio ,MARITAL status ,STATISTICAL sampling ,EDUCATIONAL attainment ,ADULTS - Abstract
Objective: The objective of this study is to evaluate the socio‐economic outcomes of survivors of childhood acute lymphoblastic leukaemia (ALL). Methods: Childhood ALL adult survivors, enrolled in EORTC trials between 1971 and 1998 in France and Belgium, were invited to fill out a questionnaire with information about their socio‐economic situation (living with a partner, having a university degree, having a job, working part time and history of having a paid job). The outcomes were compared with two matched control populations. Results: Among 1418 eligible patients, 507 (35.8%) participated, including 39 (8%) and 61 (12%) patients who received a haematopoietic stem cell transplantation (HSCT) and a cranial radiotherapy (CRT), respectively. The median time to follow‐up was 20 years, and median age was 25 years. Survivors showed a socio‐economic level at least as good as controls. HCST and CRT were associated with a higher probability of not obtaining a bachelor degree (respectively OR = 3.49, 95% CI: 1.46–8.35 and OR = 2.31, 95% CI: 1.04–5.15), HSCT was associated with unemployment (OR = 2.89, 95% CI: 1.09–7.65) and having a relapse was associated with a higher probability of not having a partner (OR = 1.88, 95% CI: 1.01–3.51) adjusting for confounders. Conclusion: Childhood ALL survivors showed a high level of socio‐economic participation. HCST and CRT were associated with poorer functioning. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Rilpivirine in HIV-1-positive women initiating pregnancy
- Author
-
Frange, Pierre, Tubiana, Roland, Sibiude, Jeanne, Canestri, Ana, Arvieux, Cédric, Brunet-Cartier, Cécile, Cotte, Laurent, Reynes, Jacques, Mandelbrot, Laurent, Warszawski, Josiane, Le Chenadec, Jérôme, Crenn-Hebert, Catherine, Floch-Tudal, Corinne, Mazy, Fabienne, Joras, Marine, Meier, Françoise, Mortier, Emmanuel, Briquet, Catherine, Ichou, Houria, Marty, Laurence, Jabbarian, Hélène, Ceccaldi, Pierre-François, Villemant, Agnès, Zarouk, Virginie, Lefort, Agnès, Ben Salah, Mariam, Hittinger, Gilles, Chamouilli, Jean-Marc, Burle, Christian, Lafeuillade, Alain, Philip, Gisèle, Lambry, Véronique, Medus, Marie, Bachelard, Germaine, Malet, Martine, Dendale-Nguyen, Joëlle, Guimard, Thomas, Guimard, Karine, Brossier, Jean-Pierre, Perre, Philippe, Esnault, Jean-Luc, Aubry, Olivier, Leautez-Nainville, Sophie, Bonnenfant, Valerie, Laine, Laeticia, Martha, Sandrine-Anne, Maurel, Elise, Francoise, Michel, Barat, Muriel, Murger, Patricia, Rouha, Mahfoud, Lévy, Marc, Lumbroso, Philippe, Checoury, Alain, Sahadatu, Osseni, Perfezou, Pascale, Blondin, Gilles, Ansart, Séverine, De Saint Martin, Luc, Le Moine, Philippe, Duthé, Jean-Charles, Daniel, Corinne, Calvez, Christian, Boutaric, Emmanuelle, Rohan, Jennifer, Bauville, Estelle, Dupre, Christelle, Lotton, Pascal, Ouamara-digue, Enora, Poinsignon, Yves, Goussef, Marie, Grelier, Anne, Mousset, Gaetane, Cudeville, Corinne, Niault, Mathilde, Belzic, Isabelle, Moreau, Philippe, Le Coz, Marie-Françoise, Vaillant, Odile Luycx, Guerin-Duplessy, Anne, Mouton-Rioux, Virginie, De Morel, Philippe, Vitrat, Virginie, Tardif, Didier, Gaillat, Jacques, Vanderbergh, Anne, Braig, Suzanne, Clavere, Gaelle, Dehlinger-Paul, Marion, Mohamed, Khaled, Echard, Marie, Camus, Michel, Mulard, Catherine, Fontelonga, Marie-Agnès, Heller-Roussin, Brigitte, Winter, Cécile, Challier, Marion, Debruyne, Elise, Marcou, Valerie, Firtion, Ghislaine, Pannier, Emmanuelle, Costa, Myriam, Launay, Odile, Salmon-Ceron, Dominique, Belkacem, Touria, Bajawi, Youcef, Aubret, Valérie Raynal, Rivaux, Danièle, Elaoun, Neila, Allal, Lahcene, Djoubou, Sandrine, Rahli, Djamila, Moine, Agnès Bourgeois, Valentin, Morgane, Damond, Florence, Huri, Virginie, Vivier, Valérie, Yahia, Fatma Ait, Garrait, Valérie, Hau, Isabelle, Touboul, Claudine, Ratsimbazafy, Lanto, Boiron, Emilie, Elharrar, Brigitte, Labaune, Jean-Marc, Rudigoz, Rene-Charles, Brochier, Corinne, Galvan, Valérie, Ogoudjobi, Stanislas, Elleau, Christophe, Runel-Belliard, Camille, Pistone, Thierry, Fleury, Hervé, Horovitz, Jacques, Sandler, Boris, Roux, Denis, Ragnaud, Jean-Marie, Chabanier, Pierre, Brun, Jean-Luc, Delveaux, Sandrine, Muanza, Blandine, Diallo, Mama Doufari, Lamaury, Isabelle, Sow, Marie-Thérèse, Samar, Ketty, Carpentier, Bénédicte, Osman, Zafer, Dienga, Etienne, Seaume, Hervé, Ducrocq, Sarah, Bailly-Salin, Philippe, Da Silva, Christelle Dusart, Fayolas, Isabelle, Abbal, Julie, Simon-Toulza, Caroline, Truillet, Véronique, Bogner, Noëlle, Chiabrando, Julie, Armand, Evelyne, Cayla, Claudine, Chacé, Anne, Matheron, Isabelle, Richier, Laurent, Miantezila, Joe, Bry, Sandrine, Couderc, Sophie, Narcy, Catherine, Routier, Corinne, Nassar, Rania, Bouldouyre, Marie-Anne, Zakaria, Ahmed, Dauphin, Hélène, Goissen, Céline, Belloy, Marie, Delassus, Jean-Luc, Favret, Véronique, Nemeth, Céline, Partisani, Marialuisa, Entz-Werlé, Natacha, Langer, Bruno, Uettwiller, Françoise, Durand, Myriam, Partizani, MariaLuisa, Cheneau, Christine, Rey, David, Ebel, Edith, Fischer, Patricia, DAVID, Eric, Vayssière, Christophe, Weil, Michèle, Schmitt, Marie Paule, Nisand, Israël, Genet, Philippe, Brault, Dominique, Allisy, Christine, Gerbe, Juliette, Masse, Virginie, Wifaq, Bouchra, Courdavault, Laurence, Gabor, Petra, Tordjeman, Nathalie, Lebrette, Marie-Gisèle, Selleret, Lise, Samama, Déborah, Bolot, Pascal, Khuong-Josses, Marie-Aude, Amel, Mahdi, Bounan, Stéphane, Nourry, Christelle, Andris, Sabine, Blanche, Stephane, Driessen, Marine, Veber, Florence, Fischer, Alain, Rouzioux, Christine, Avettand-Fenoël, Véronique, Mahlaoui, Nizar, Mourey, Marie-Christine, Granier, Michèle, Devidas, Alain, Donnadieu, Anne-Claire, May, Adrien, Chabrol, Amélie, Chevojon, Pierre, Bellahcene, Chahrazede, Sanchez, Audrey, Malbrunot, Claire, Neizelien, Joelle, Agher, Nouara, Pluchart, Claire, Rouger, Christine, Dommergues, Marc, Bonmarchand, Manuela, Shneider, Luminata, Caby, Fabienne, Calin, Ruxandra-Oana, Blanc, Christine, Lupin, Catherine, Pauchard, Michèle, Yangui, Mohamed Amine, Roca, Didier, Todorova, Darina, Laurent, Juliette, Ferry, A., Deschaud, Martine, Blum, Laurent, Chambrin, Véronique, Labrune, Philippe, Clech, Laure, Raho-Moussa, Mariem, Pauly-Ravelly, Isolde, Jault, Thierry, Bouabdallah, Soufiane, Sanchez, Lydie, Sanchez, Anita, Johnson, Ama, Louchard, Agnès, Allouche, Claude, Pathe, Jean-Paul, Lachassine, Eric, Benoist, Laurence, Jeantils, Vincent, Delannoy, Catherine, Benbara, Amélie, Carbillon, Lionel, Borgne, Anne, Moreau, Laurence, PICARD, Fabienne, Karaoui, Leïla, Elbert, Véronique Lefevre, Balaz, Valérie, Bongain, André, Monpoux, Fabrice, Deville, Anne, Galiba, Eliane, Jabbar, Ahmed, Joutel, Martine, Schmidt, Jean-Luc, Decaux, Nathalie, Cravello, Ludovic, Errichiello, Katia, Hubert, Claire, Dollfus, Catherine, Hervé, François, Tabone, Marie-Dominique, Courcoux, Mary-France, Leverger, Guy, Kayem, Gilles, Schnurgier, Aurélie, Jensen, Aurore, Vaudre, Geneviève, Pinquier, Didier, Gromez, Alexis, Pinto-Cardoso, Gaelle, Faye, Albert, Borie, Constance, Levine, Martine, Matheron, Sophie, Marouts, Erianna Bellaton, Boissinot, Christine, Caseris, Marion, Pommelet, Virginie, Morau, Geneviève, Leveille, Sandrine, Boumediene, Marie Astride, Garion, Dominique, Peretti, Delphine, Fourcade, Corinne, Houllier, Marie, Jrad, Ikram, Bourdic, Katia, Monnier, Sylvie, Chirouze, Catherine, Proust, Aurélie, Catteau, Odile, Gardiennet, Quentin, Reliquet, Véronique, Winer, Norbert, Vaucel, Edouard, Rodallec, Audrey, Garnier-André, Elisabeth, Briandet, Claire, Brouard, Jacques, Goubin, Pascale, Beucher, Gaël, Dina, Julia, Demersay, Arnaud Chalvon, Tassi, Sylvie, Lavarenne, Gaelle, Rajguru, Mandovi, Messaoudi, Fabienne, Carré, Nathalie, Rajguru, Mandavi, Bobrie-Moyrand, Claire, Foucaud, Pierre, Bernard, Louis, Maakroun, Zoha, Bourgault, Olivier, Kebaili, Kamila, Bertrand, Yves, Alixe, Véronique, Boyer, Emeline, Billiemaz, Kareen, Fanget, Cécile, Ronat, Véronique, Lesauder, Catherine, Lavastre, Marie Laure, Moulin, Alice, Turquini, Marie-France, Colombani, Dominique, Belgodere, Danièle, Fialaire, Pascale, Proust, Stéphanie, Rehaiem, Sami, Mesnard, Louis, Werner, Evelyne, Dukiel, Nathalie, Desmergers, Baya, Blanc-Ruffat, Isabelle, Maraux, Barbara, Coursol, Anne, Castaneda, Julie, Etienne, Lise, Vintejoux, Emmanuelle, Lalande, Muriel, Segondy, Michel, Guigue, Nelly, De Gennes, Christiane, Clavel, Cyril, Cazassus, François, Walter, Véronique, Mazingue, Françoise, Hammou, Yamina, Lagree, Marion, Paquiez, Odile, D’angelo, Sophie, Boquet, Laurence, Ajana, Faiza, Hatchuel, Yves, Nahri, Imad, Zebelus, Jenny, Genet, Claire, Ducroix-Roubertou, Sophie, Aubrard, Yves, Constanty, Anne, Weinbreck, Pierre, Piet, Emilie, Jacquier, Françoise, Michaud, Christophe, Safwan, Hassan, Boutet, Arnaud, Grand-Courault, Carole, Autret, Fanny, Habibi, Fakher, Azria, Elie, Abdelhadi, Mohamed, Elenga, Narcisse, Bocket, Laurence, Taillet, Françoise, Palenzuela, Gilles, Khadly, Redouane, Pierronnet, Danielle, Dos-Santos, Emmanuelle, David, Selva, Makhloufi, Djamila, Brunel-Dalmas, Florence, Carbonnel-Delalande, Elisabeth, Chiarello, Pierre, Godinot, Matthieu, Gilbert, Sylvie, Massardier, Jérôme, Gauthier-Moulinier, Hélène, Fernandes, Elisabeth, Ranaivojaona, Sata, Chevry, Coralie, CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Maladies infectieuses et tropicales [CHU Tenon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], CHU Pontchaillou [Rennes], Centre hospitalier universitaire de Nantes (CHU Nantes), Département de maladies infectieuses, Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Hôpital Louis Mourier - AP-HP [Colombes], Chirurgie Gynécologique et Obstétrique (CGO), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département d'infectiologie [AP-HP Hôpital Louis Mourier, Colombes], Faculté de Médecine Paris-Diderot [Paris], Université Paris Diderot - Paris 7 (UPD7), Service de Médecine Interne [AP-HP, CHU Beaujon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Beaujon [AP-HP], Service de médecine interne, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, Service de pédiatrie, Centre Hospitalier Chalon-sur-Saône William Morey, CH de Lorient, Laboratoire de Traitement de l'Information Medicale (LaTIM), Université européenne de Bretagne - European University of Brittany (UEB)-Université de Brest (UBO)-Télécom Bretagne-Institut Mines-Télécom [Paris] (IMT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Unité d'hémato-oncologie, CHU Toulouse [Toulouse], Pôle Médico-Chirurgical de Pédiatrie et de Génétique Clinique, Néonatologie, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Service de Gynécologie et Obstétrique [Rennes] = Gynaecology [Rennes], CH Bretagne Sud, Centre d'Investigations Biomédicales - Hématologie - Oncologie - Greffes (CIB-HOG), Centre d'Investigations Biomédicales - Hématologie - Oncologie - Greffes-Hopital St Louis, Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], Service des Maladies Infectieuses, Centre Hospitalier de la Région d'Annecy (Pringy), University of Warwick [Coventry], Physiopathologie et Pharmacotoxicologie Placentaire Humaine (U1139), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Cochin [AP-HP], Université Paris Descartes - Paris 5 (UPD5), Service de Virologie [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Hôpital de la Croix-Rousse [CHU - HCL], Réseau périnatal Aurore, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), CHU Bordeaux [Bordeaux], pôle gynécologie-obstétrique et médecine foetale, Laboratoire Rhéologie et Procédés (LRP), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP ), Université Grenoble Alpes (UGA), Fédération des Maladies Infectieuses [Bordeaux], CHU de Bordeaux Pellegrin [Bordeaux], Centre de compétences des microangiopathies thrombotiques, department of pathology, university hospital, parakou, CHU Pointe-à-Pitre/Abymes [Guadeloupe], Service des Maladies Infectieuses et Tropicales[Point-à-Pitre], Service de Gynécologie-Obstétrique [Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Hôpital Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), CHU Strasbourg, Développement et physiopathologie de l'intestin et du pancréas, Institut National de la Santé et de la Recherche Médicale (INSERM), Service de gynécologie–obstétrique, CHU Strasbourg-Hôpital de Hautepierre [Strasbourg], CHRU Strasbourg, Département d'échographie et de Médecine fœtale, SIHCUS-CMCO, Service de Gynécologie-Obstétrique, CHI Poissy-Saint-Germain, Centre Hospitalier Victor Dupouy, Service d'informatique médicale et biostatistiques [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Hôpital d'Argenteuil, Centre Hospitalier de Saint-Denis [Ile-de-France], Hôpital Delafontaine, Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants (UMR_S 953), Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de microbilogie & unité d'immunologie, hématologie et rhumatologie pédiatriques, Developpement Normal et Pathologique du Système Immunitaire, Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Chaire Médecine expérimentale (A. Fischer), Collège de France (CdF (institution)), Laboratoire de Virologie [CHU Necker], Université Sorbonne Paris Cité (USPC), IFR Necker-Enfants Malades (IRNEM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Médecine néonatale, Centre Hospitalier Sud Francilien, Service de pneumologie [Béclère], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Centre Hospitalier Universitaire de Reims (CHU Reims), Service de Gynécologie-Obstétrique, Maternité, Chirurgie Gynécologique [CHU Pitié-Salpêtrière], Service de médecine interne [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Croissance cellulaire, réparation et régénération tissulaires (CRRET), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Centre National de la Recherche Scientifique (CNRS), Hôpital Antoine Béclère, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Référence Maladies Héréditaires du Métabolisme Hépatique [Hôpital Antoine Béclère - APHP (CRMR), Service de rhumatologie [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Service de gynécologie-obstétrique [Hôpital Jean Verdier], Université Paris 13 (UP13)-Hôpital Jean Verdier [AP-HP], Service de Gynécologie-Obstétrique-Reproduction, Hôpital l'Archet, Service d'Hémato-oncologie Pédiatrique [CHU Nice], Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Trousseau [APHP], Service d'hématologie-immunologie-oncologie pédiatrique [CHU Trousseau], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Service des maladies infectieuses et tropicales, Service de pédiatrie générale, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7), Institut Pasteur du Laos, Réseau International des Instituts Pasteur (RIIP), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Service de Gynécologie Obstétrique, Service de Médecine Interne et Immunologie clinique [AP-HP Hôpital Bicêtre], Hôpital Bicêtre, Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), service de maladies infectieuses CHU J Minjoz Besancon, Service des maladies infectieuses et tropicales [CHU Nantes], Physiopathologie des Adaptations Nutritionnelles (PhAN), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service de virologie [CHU Nantes], Service de Pédiatrie Enfants - Hématologie Oncologie [CHU de Dijon], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de Pédiatrie Médicale [Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Service de Gynécologie-Obstétrique et Médecine de la Reproduction [CHU Caen], Service de Virologie [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Service de Médecine Interne et Maladies Infectieuses [Tours], Service d'hématologie : Immuno-Hématologie pédiatrique et transplantation de moelle osseuse, Hôpital Debrousse, CHU Saint-Etienne, Centre population et développement (CEPED - UMR_D 196), Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5), Médecine Néonatale et Réanimation Pédiatrique, CH René Dubos, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Hôpital Jeanne de Flandres, Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service des Maladies Infectieuses et Tropicales [Hôpital Gustave Dron, Tourcoing], Centre Hospitalier Gustave Dron [Tourcoing], 'Personal Protection Against Vectors' working group (PPAV), PPAV working group, Service des Maladies infectieuses et tropicales [CHU Limoges], CHU Limoges, Equipe de Recherche Médicale Appliquée (ERMA), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), CHU Annecy, Service de Pédiatrie, Centre hospitalier de Saint-Nazaire, EA 3593 Université des Antilles et de la Guyane, Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], Laboratoire de virologie [CHU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de Maladies Infectieuses et Tropicales [Hôpital de la Croix-Rousse - HCL], Service d'immunologie, Hospices Civils de Lyon (HCL)-Hôpital Edouard Herriot [CHU - HCL], Hôpital Femme Mère Enfant [CHU - HCL] (HFME), Centre Hospitalier de Basse-Terre, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Université de Rennes (UR), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Collège de France - Chaire Médecine expérimentale (A. Fischer), Laboratoire Chrono-environnement (UMR 6249) (LCE), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), ANRS CO1/CO11, French national, Viral Hepatitis, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Service des maladies infectieuses et tropicales [CHU Tenon], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Université européenne de Bretagne - European University of Brittany (UEB)-Télécom Bretagne-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Mines-Télécom [Paris] (IMT), Hôpital des Enfants, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris-Sud - Paris 11 (UP11), CH Evry-Corbeil-CH Evry-Corbeil, CH Evry-Corbeil, Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Jean Verdier [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris 13 (UP13), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Laboratoire d'Electrotechnique de Lyon (LEL), École Centrale de Lyon (ECL), Université de Lyon-Université de Lyon, Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Université de Limoges (UNILIM)-CHU Limoges, Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )-Université de Montpellier (UM)
- Subjects
rilpivirine ,viral suppression ,hiv ,hiv-1 ,pregnancy ,conception ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,virology - Abstract
International audience; BackgroundSafety data about rilpivirine use during pregnancy remain scarce, and rilpivirine plasma concentrations are reduced during second/third trimesters, with a potential risk of viral breakthroughs. Thus, French guidelines recommend switching to rilpivirine-free combinations (RFCs) during pregnancy.ObjectivesTo describe the characteristics of women initiating pregnancy while on rilpivirine and to compare the outcomes for virologically suppressed subjects continuing rilpivirine until delivery versus switching to an RFC.MethodsIn the ANRS-EPF French Perinatal cohort, we included women on rilpivirine at conception in 2010–18. Pregnancy outcomes were compared between patients continuing versus interrupting rilpivirine. In women with documented viral suppression (
- Published
- 2020
- Full Text
- View/download PDF
41. Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study
- Author
-
Rossi, Giovanna, Kicinski, Michal, Suciu, Stefan, Vandecruys, Els, Plat, Geneviève, Uyttebroeck, Anne, Paillard, Catherine, Barbati, Mélissa, Dresse, Marie-Françoise, Simon, Pauline, Minckes, Odile, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Millot, Frédéric, van der Werff Ten Bosch, Jutte, Chantrain, Christophe, Paulus, Robert, de Rojas, Teresa, de Schaetzen, Gaetan, Rohrlich, Pierre, Benoît, Yves, Piette, Caroline, Rossi, Giovanna, Kicinski, Michal, Suciu, Stefan, Vandecruys, Els, Plat, Geneviève, Uyttebroeck, Anne, Paillard, Catherine, Barbati, Mélissa, Dresse, Marie-Françoise, Simon, Pauline, Minckes, Odile, Pluchart, Claire, Ferster, Alina, Freycon, Claire, Millot, Frédéric, van der Werff Ten Bosch, Jutte, Chantrain, Christophe, Paulus, Robert, de Rojas, Teresa, de Schaetzen, Gaetan, Rohrlich, Pierre, Benoît, Yves, and Piette, Caroline
- Abstract
STUDY QUESTION: What are the fertility outcomes of male and female childhood acute lymphoblastic leukaemia (ALL) long-term survivors? SUMMARY ANSWER: We observed similar fertility outcomes in both male and female childhood ALL survivors compared with the general population, with the exception of a higher proportion of miscarriages among partners of male survivors. WHAT IS KNOWN ALREADY: Survival after childhood ALL is currently >90% and fertility impairments are among the main concerns of the long-term survivors. Few studies have focused on the fertility issues within this selected population and the existing data are difficult to interpret due to the different treatment regimens received by the patients, the small sample sizes and the unavailability of control data in many studies. STUDY DESIGN, SIZE, DURATION: Childhood ALL patients enrolled in European Organisation for Research and Treatment of Cancer (EORTC) studies between 1971 and 1998 in France and Belgium, <18 years old at diagnosis and alive and ≥18 years at follow-up were eligible. Among 1418 eligible survivors, 507 (35.8%) participated (277 females, 230 males). Controls from the general population matched one to one by age, province, level of urbanization and sex could be identified for 503 survivors. PARTICIPANTS/MATERIALS, SETTING, METHODS: Survivors and controls were invited to fill out a questionnaire including information about their menstrual cycles (for females), intention to have children, having children, use of medical help to become pregnant and occurrence of negative pregnancy outcomes (birth defect, miscarriage, medical abortion or stillbirth). The results were analysed separately for females and males. The association between age at diagnosis and fertility outcomes, adjusted by age at follow-up, study and country were investigated using logistic regression. MAIN RESULTS AND THE ROLE OF CHANCE: The median time since diagnosis was 20.1 years and the median age at follow-up was 25 years. There, SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2021
42. CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951
- Author
-
Sirvent, Nicolas, Suciu, Stefan, De Moerloose, Barbara M J B., Ferster, Alina, Mazingue, Françoise, Plat, Geneviève, Yakouben, Karima, Uyttebroeck, Anne, Paillard, Catherine, Costa, Vitor, Simon, Pauline, Pluchart, Claire, Poirée, Marilyne, Minckes, Odile, Millot, Frédéric, Freycon, Claire, Maes, Philip, Hoyoux, Claire, Cavé, Hélène, Rohrlich, Pierre, Bertrand, Yves, Benoît, Yves, Sirvent, Nicolas, Suciu, Stefan, De Moerloose, Barbara M J B., Ferster, Alina, Mazingue, Françoise, Plat, Geneviève, Yakouben, Karima, Uyttebroeck, Anne, Paillard, Catherine, Costa, Vitor, Simon, Pauline, Pluchart, Claire, Poirée, Marilyne, Minckes, Odile, Millot, Frédéric, Freycon, Claire, Maes, Philip, Hoyoux, Claire, Cavé, Hélène, Rohrlich, Pierre, Bertrand, Yves, and Benoît, Yves
- Abstract
Aim: To evaluate the prognostic significance of initial central nervous system (CNS) involvement of children with acute lymphoblastic leukemia (ALL) enrolled in the EORTC 58951 trial. Patients and methods: From 1998 to 2008, 1930 ALL patients were included in the randomized EORTC 58951 trial. Overall treatment intensity was adjusted according to known prognostic factors including the level of minimal residual disease after induction treatment. CNS-directed therapy comprised four to 11 courses of i.v. methotrexate (5 g/m2), and 10 to 19 intrathecal chemotherapy injections, depending on risk group and CNS status. Cranial irradiation was omitted for all patients. Results: The overall 8-year event-free survival (EFS) and overall survival (OS) rates were 81.3% and 88.1%, respectively. In the CNS-1, TPL+, CNS-2, and CNS-3 groups, the 8-year EFS rates were 82.1%, 77.1%, 78.3%, and 57.4%, respectively. Multivariable analysis indicated that initial CNS-3 status, but not CNS-2 or TLP+, was an independent adverse predictor of outcome. The 8-year incidence of isolated CNS relapse was 1.7% and of isolated or combined CNS relapse it was 3.7%. NCI high-risk group, male sex, CNS-2 and CNS-3 status were independent predictors for a higher incidence of any CNS relapse. Conclusions: CNS-3 status remains associated with poor prognosis and requires intensification of both systemic and CNS-directed therapy. This trial was registered at https://clinicaltrials.gov/under/NCT00003728., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2021
43. Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
- Author
-
Thebault, Eric, primary, Piperno-Neumann, Sophie, additional, Tran, Diep, additional, Pacquement, Hélène, additional, Marec-Berard, Perrine, additional, Lervat, Cyril, additional, Castex, Marie-Pierre, additional, Cleirec, Morgane, additional, Bompas, Emmanuelle, additional, Vannier, Jean-Pierre, additional, Plantaz, Dominique, additional, Saumet, Laure, additional, Verite, Cecile, additional, Collard, Olivier, additional, Pluchart, Claire, additional, Briandet, Claire, additional, Monard, Laure, additional, Brugieres, Laurence, additional, Le Deley, Marie-Cécile, additional, and Gaspar, Nathalie, additional
- Published
- 2021
- Full Text
- View/download PDF
44. Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease
- Author
-
Cyrta, Joanna, primary, Gauthier, Arnaud, additional, Karanian, Marie, additional, Vieira, Andre F., additional, Cardoen, Liesbeth, additional, Jehanno, Nina, additional, Bouvet, Mégane, additional, Bouvier, Corinne, additional, Komuta, Mina, additional, Le Loarer, François, additional, Orbach, Daniel, additional, Rome, Angélique, additional, Minard-Colin, Véronique, additional, Brichard, Bénédicte, additional, Pluchart, Claire, additional, Thebaud, Estelle, additional, Renard, Marleen, additional, Pannier, Stéphanie, additional, Brisse, Hervé, additional, Petit, Philippe, additional, Benoist, Camille, additional, Schleiermacher, Gudrun, additional, Geoerger, Birgit, additional, Vincent-Salomon, Anne, additional, Fréneaux, Paul, additional, and Pierron, Gaëlle, additional
- Published
- 2021
- Full Text
- View/download PDF
45. Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study
- Author
-
Journy, Neige Marie Yvanne, primary, Zrafi, Wael Salem, additional, Bolle, Stéphanie, additional, Fresneau, Brice, additional, Alapetite, Claire, additional, Allodji, Rodrigue Setcheou, additional, Berchery, Delphine, additional, Haddy, Nadia, additional, Kobayashi, Isao, additional, Labbé, Martine, additional, Pacquement, Hélène, additional, Pluchart, Claire, additional, Schwartz, Boris, additional, Souchard, Vincent, additional, Thomas-Teinturier, Cécile, additional, Veres, Cristina, additional, Vu-Bezin, Giao, additional, Diallo, Ibrahima, additional, and de Vathaire, Florent, additional
- Published
- 2021
- Full Text
- View/download PDF
46. MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA
- Author
-
Dufour, Christelle, primary, Masliah-Planchon, Julien, additional, Delisle, Marie-Bernadette, additional, Geoffray, Anne, additional, Abbas, Rachid, additional, Bourdeaut, Franck, additional, Bertozzi, Anne-Isabelle, additional, Faure-Conter, Cecile, additional, Chappe, Celine, additional, De Carli, Emilie, additional, Entz-Werle, Natacha, additional, Fouyssac, Fanny, additional, Andre, Nicolas, additional, Soler, Christine, additional, Pluchart, Claire, additional, Palenzuela, Gilles, additional, Leblond, Pierre, additional, and Grill, Jacques, additional
- Published
- 2020
- Full Text
- View/download PDF
47. A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?
- Author
-
Pluchart, Claire, primary, Barbe, Coralie, additional, Poitevin, Gael, additional, Audonnet, Sandra, additional, and Nguyen, Philippe, additional
- Published
- 2020
- Full Text
- View/download PDF
48. Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)
- Author
-
de Tersant, Marie, primary, Généré, Lucile, primary, Freyçon, Claire, primary, Villebasse, Sophie, primary, Abbas, Rachid, primary, Barlier, Anne, primary, Bodet, Damien, primary, Corradini, Nadège, primary, Defachelles, Anne-Sophie, primary, Entz-Werle, Natacha, primary, Fouquet, Cyrielle, primary, Galmiche, Louise, primary, Gandemer, Virginie, primary, Lacour, Brigitte, primary, Mansuy, Ludovic, primary, Orbach, Daniel, primary, Pluchart, Claire, primary, Réguerre, Yves, primary, Rigaud, Charlotte, primary, Sarnacki, Sabine, primary, Sirvent, Nicolas, primary, Stephan, Jean-Louis, primary, Thebaud, Estelle, primary, Gimenez-Roqueplo, Anne-Paule, primary, and Brugières, Laurence, primary
- Published
- 2020
- Full Text
- View/download PDF
49. Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM).
- Author
-
Bejarano-Quisoboni, Daniel, Pelletier-Fleury, Nathalie, Allodji, Rodrigue S., Lacour, Brigitte, GrosClaude, Pascale, Pacquement, Hélène, Doz, François, Berchery, Delphine, Pluchart, Claire, Bondiau, Piere-Yves, Nys, Julie, Jackson, Angela, Demoor-Goldschmidt, Charlotte, Dumas, Agnès, Thomas-Teinturier, Cécile, Vu-Bezin, Giao, Valteau-Couanet, Dominique, Haddy, Nadia, Fresneau, Brice, and de Vathaire, Florent
- Subjects
MEDICAL care costs ,CHILDHOOD cancer ,CANCER survivors ,MEDICAL care ,CANCER hospitals ,CENTRAL nervous system - Abstract
Background: Childhood cancer survivors (CCS) may require lifelong medical care due to late effects of cancer treatments. Little is known about of their healthcare utilization and expenditures at long-term especially in publicly funded health care system. We aim to estimate and describe the health care expenditures among long-term CCS in France. Methods: A total of 5319 five-year solid CCS diagnosed before the age of 21 between 1945 and 2000 in France were identified in the French Childhood Cancer Survivors Study cohort (FCCSS) and the French cancer registry. Information about health care expenditure was taken from the French national health data system between 2011 and 2016, and was described according to survivors' characteristics. Generalized linear models were used to determine associations between health care expenditures and survivors' characteristics. Results: Mean annual amount of healthcare expenditures was € 4,255. Expenditures on hospitalizations and pharmacy represents 60% of total expenditures. Mean annual of healthcare expenditures were higher at increasing age, among women survivors (€ 4,795 vs € 3,814 in men) and in central nervous system (CNS) tumor survivors (€ 7,116 vs € 3,366 in lymphoma and € 3,363 in other solid tumor survivors). Conclusions: Childhood cancer survivorship is associated with a substantial economic burden in France. We found that female gender and CNS primary cancer were associated with increased healthcare expenditures. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
50. Therapeutic approach and outcome of children with Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study.
- Author
-
Aubert, Lucie, Petit, Arnaud, Bertrand, Yves, Ray‐Lunven, Anne‐France, Angoso, Marie, Pluchart, Claire, Millot, Frédéric, Saultier, Paul, Cheikh, Nathalie, Pellier, Isabelle, Plantaz, Dominique, Sirvent, Anne, Thouvenin‐Doublet, Sandrine, Valduga, Julie, Plat, Geneviève, Rialland, Fanny, Henry, Catherine, Esvan, Maxime, Gandemer, Virginie, and Ray-Lunven, Anne-France
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.